Apollo Endosurgery (NASDAQ:APEN Get Rating) and Pulse Biosciences (NASDAQ:PLSE Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, risk, dividends, ...
This price move could be a signal that APEN may fall back below the higher band and head toward the middle band. Traders may consider selling the stock, shorting the stock, or exploring put options...
This is a signal that APEN's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...
Morris Financial Concepts Inc. acquired a new position in Apollo Endosurgery, Inc. (NASDAQ:APEN Get Rating) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund acquired 11,149 shares of the biotechnology companys stock, valued at ...
Apollo Endosurgery, Inc. (NASDAQ:APEN Get Rating) was the recipient of a large increase in short interest in the month of February. As of February 28th, there was short interest totalling 618,900 shares, an increase of 9.3% from the February 13th total of 566,200 shares. Based on an average daily ...